CD8A and anemia: Compared with those before treatment, the levels of CD3+ and CD4+ and the ratio of CD4/CD8 in both groups increased significantly after treatment, indicating that long-term administration of iron proteinsuccinylate can significantly improve the immunity of children, thereby effectively reducing the incidence of complications caused by iron deficiency anemia in children.